| First Author | Reis AS | Year | 2020 |
| Journal | Sci Adv | Volume | 6 |
| Issue | 10 | Pages | eaax6346 |
| PubMed ID | 32181339 | Mgi Jnum | J:297921 |
| Mgi Id | MGI:6479409 | Doi | 10.1126/sciadv.aax6346 |
| Citation | Reis AS, et al. (2020) Inflammasome activation and IL-1 signaling during placental malaria induce poor pregnancy outcomes. Sci Adv 6(10):eaax6346 |
| abstractText | Placental malaria (PM) is associated with severe inflammation leading to abortion, preterm delivery, and intrauterine growth restriction. Innate immunity responses play critical roles, but the mechanisms underlying placental immunopathology are still unclear. Here, we investigated the role of inflammasome activation in PM by scrutinizing human placenta samples from an endemic area and ablating inflammasome components in a PM mouse model. The reduction in birth weight in babies from infected mothers is paralleled by increased placental expression of AIM2 and NLRP3 inflammasomes. Using genetic dissection, we reveal that inflammasome activation pathways are involved in the production and detrimental action of interleukin-1beta (IL-1beta) in the infected placenta. The IL-1R pharmacological antagonist Anakinra improved pregnancy outcomes by restoring fetal growth and reducing resorption in an experimental model. These findings unveil that IL-1beta-mediated signaling is a determinant of PM pathogenesis, suggesting that IL-1R antagonists can improve clinical outcomes of malaria infection in pregnancy. |
